FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
forum

SBIN Share Price Target

State Bank of India
Sector: Banks
... Read more
SBIN Share Price *
318.4 -17.8 (-5.29%)
* (quote may be delayed)
SBIN Share Price Forecast - Consensus
No. of reports in last year
38
No. of analysts
18
Average Consensus Forecast
373.00
Consensus Potential
9.36%

SBIN Share Price Target - Broker Reports - 2019

Geojit Financial Services
1-Nov-19
Price @ Call: 312.65
Target: 398
BUY
State Bank of India is India’s largest bank. The bank operates 21,929 branches globally and has a vast network of 58,567 ATMs/CDMs. It provides a wide range of financial services, such as insurance, credit cards and asset management, through its subsidiaries. Net interest income grew 17.7% YoY to Rs. 24,600cr while Domestic net interest margin (NIM) expanded 21bps QoQ/42bps YoY. Lower-cost CASA deposits improved 8.1% YoY, however CASA ratio declined 14bps YoY to 45.1%. Gross loans & advances rose 8.7% YoY, as domestic and foreign loans grew 8.4% and 10.1%, respectively. GNPA/NNPA ratio improved to 7.2%/2.8% in Q2FY20 (vs. 9.9%/4.8% in Q2FY9). Capital adequacy ratio elevated to 13.8% (+98bps YoY). We retain our Buy rating on SBI with a target price of Rs 398 (SOTP).
... Read more

ICICIdirect.com
30-Oct-19
Price @ Call: 280.5
Target: 400
BUY

Prabhudas Lilladher
30-Oct-19
Price @ Call: 286.87
Target: 413
BUY
SBI hosted an investor day showcasing its business strategy and future roadmap in the medium term. Management remains highly focused on improving its core operating profit & reaching ROAs towards 1.0% by end of FY21. Key enablers will be (i) improving NIMs from lower cost of funds, lower interest reversals and risk based pricing on loans (ii) steady fee income generation & opex control below 10% or C/I of 45% (from current 50-55%) and (iii) credit cost of <100bps with slippages of 1.5% assuming LGDs of 50-60% in base line scenario. Bank on consolidated basis also sees huge value addition by subsidiaries in SBI eco system for non-lending financial products and will monetize the same ahead. Bank’s baseline scenario of PPOP Rs650bn & Rs750bn in FY20/FY21E can be achievable but we vary on ROAs of 0.9%-1.0% by FY21 as timing of provisions on new stressed assets will have to be upfront & write-back from recoveries can be delayed despite large cushion available. We retain BUY with revised TP of Rs413 (from Rs396) as we slightly up valuations in subsidiaries with bank estimates unchanged.
... Read more

Nirmal Bang
29-Oct-19
Price @ Call: 282.05
Target: 365
BUY
State Bank of India (SBI) reported its 2QFY20 results with the key pointers being: (1) Net reduction in GNPAs was Rs. 68.58 bn, marking a continued trend in asset quality improvement. Exceptional gains were used for upfront provisioning and (2) NIM expansion has been a function of declining cost of deposits as well as increasing yields (see detailed analyst meet takeaways on page 2 for significant incremental colour). Per se, on the key P&L items, SBI posted NII growth of 18% YoY at Rs246.0bn, PPOP growth of 19% YoY at Rs147.1bn and PAT growth of 219% YoY at Rs 30.1bn. We have revised our estimates for FY20/FY21/FY22 and retained Buy rating on SBI, revising our target price to Rs365 (from Rs399 earlier), valuing the standalone entity at 0.8x H1FY22E P/ABV and ascribing a value of Rs96 for subsidiaries.
... Read more

HDFC Securities
26-Oct-19
Price @ Call: 276.24
Target: 389
BUY
A qtr mostly full of positives, 2Q saw improvement in SBIN’s asset quality as slippages halved and NIM, PCR further expanded. However, there’s more than meets the eye. Maintain BUY with an SOTP of Rs 389 (1.3x Sept-21E ABV of Rs 232 + Rs 87 sub value). While SBIN surprised with a sharp improvement in performance across fronts (reduction in reported stress, NIM expansion and better coverage), we are a tad weary of the sustainability of the pace of this improvement. No material progress has been on large IBC cases and further standard exposure to vulnerable sectors/entities does not bode well for stress; the recent spate of ratings downgrades does not help, either. Still, the worst in terms of asset quality is long behind. This underpins our BUY.
... Read more

Prabhudas Lilladher
25-Oct-19
Price @ Call: 276.24
Target: 396
BUY
SBI’s earnings of Rs30.1bn (PLe: Rs26.3bn) was better as (i) not adopting lower tax rate hence not resulting in markdown in DTA (ii) relatively strong NII & recovery from w.off. Key positive was much lower fresh slippages of Rs88.0bn with all segments declining especially retail & corporate. Also o/s SMA & stress a/c under new resolution framework saw marginal decline to 1.4% of loans v/s 1.5% in Q1FY20. Operationally bank has been improving with near industry growth & upward NIMs trajectory, opex control and much better PCR and hence, has the ability to absorb hits from existing stress assets, although if additional assets come under stress earnings will see slower recovery. We retain BUY with revised TP of Rs396 (from Rs388) on higher SBI life share in SOTP.
... Read more

Sushil Finance
11-Sep-19
Price @ Call: 283.13
Target: 352
BUY

Motilal Oswal
6-Aug-19
Price @ Call: 301.06
Target: 380
BUY
After reporting a benign slippage rate over the past few quarters, SBIN has again reported an increase in slippage trajectory, reflecting the deterioration in the underlying lending environment. The bank has lowered its guidance on core RoA to ~0.6% (excluding NCLT write-backs) and increased the credit cost guidance to 1.4% for FY20. We cut our FY20/21 earnings estimates by 14%/11% to factor in higher credit cost/slippages. The bank’s core operating profitability is likely to improve, led by expansion in margins and cost control, which will help mitigate some credit cost pressures. We, thus, revise our target price to INR 380 (1.2x FY21E ABV). Maintain Buy.
... Read more

ICICIdirect.com
5-Aug-19
Price @ Call: 308.45
Target: 400
BUY
The management continues to be confident that balance sheet has been repaired & guides for strong recovery (~| 17000 crore) and modest target of 12% credit growth. We factor in fresh fund raising of | 20000 crore in H2FY20E. We marginally raise slippages, thereby leading to higher provision which impacts our PAT estimates by ~12%/5% in FY20E/21E respectively. We maintain target price at | 400, valuing core bank at 1.5x FY21E ABV & subsidiary at |90, post 10% holdco discount, factoring in <2% slippage ratio, 0.6% RoA (vs.0.8% earlier) & 10-12% RoE guidance by management.
... Read more

Nirmal Bang
5-Aug-19
Price @ Call: 308.45
Target: 370
BUY
We have revised our NII estimates by 3.2%/3.2%, PPOP estimates by -0.5%/-2.9% and PAT estimates by -17.2%/-5.1% for FY20/FY21, respectively. We have valued the standalone entity at 0.9x FY21E P/ABV, ascribing a value of Rs83 for subsidiaries and revising our target price on it to Rs370 (from Rs430 earlier).
... Read more

HDFC Securities
5-Aug-19
Price @ Call: 297.02
Target: 398
BUY
SBIN’s mostly in line operating performance in 1QFY20 was marred by higher than expected slippages. Additional stress and slower resolutions will delay the expected RoAA improvement. Maintain BUY. Our SOTP (1.3x Jun- 21E ABV of Rs 228 + Rs 101 sub value) is Rs 398. After sustained improvement over FY19, SBIN disappointed on asset quality in 1QFY20. Slower than expected resolution in NCLT cases, a buildup in anticipated stress and deteriorating macros are likely to postpone RoAA improvement (as credit costs rise). Our earnings estimates are highly sensitive to asset resolution outcomes. Nevertheless, the worst is long behind SBIN (in terms of asset quality).
... Read more

Sharekhan
2-Aug-19
Price @ Call: 315.05
Target: 380
BUY
SBI trades at 1.3x its FY2021E book value, which we believe is reasonable considering it to have better operating metrics in the PSU space. We have been conservative in our estimates, and, so, while the bank has revised its credit cost/ROA outlook, we maintain our FY2020E/ FY2021E earnings. Thus, we maintain our Buy rating on the stock with a revised PT of Rs. 380.
... Read more

Prabhudas Lilladher
2-Aug-19
Price @ Call: 315.05
Target: 369
BUY
The incremental stress creates higher potential risk to asset quality and provisions impacting improvement in earnings, while stress from non-corporate also remains high especially Agri/SME. We factor in marginal hits to asset quality & earnings (increase CC to 195bps from 140bps for FY20) with revised TP of Rs369 (from Rs427) and retain BUY with valuations still being reasonable at 1.1x core ABV.
... Read more

Motilal Oswal
2-Aug-19
Price @ Call: 315.05
Target: 380
BUY

Indiabulls Ventures
26-Jun-19
Price @ Call: 356.5
Target: 435
BUY

Elara Capital
17-May-19
Price @ Call: 315.2
Target: 352
ACCUMULATE
Core operating performance is expected to improve in FY20E. NPL recovery in IBC cases and gains from subsidiaries stake sale would push return ratios in FY20. We expect an ROA of 60bp in FY20E and 80bp in FY21E. We reiterate Accumulate with revised TP of INR 352 from INR 332 and determine SBI (standalone banking entity) value at INR 274 from INR 257 at 1.3x (unchanged) one-year forward P/ABV and INR 78 (from INR 75) towards key subsidiaries.
... Read more

KRChoksey
16-May-19
Price @ Call: 311.6
Target: 351
ACCUMULATE
State Bank of India is currently trading at a P/Adj.BV multiple of 1.16x/1.04x on FY20E/FY21E book value and we expect the valuation of the bank to improve on back of its improving ROE outlook and asset quality metrics. The bank’s expanding retail franchisee supports asset yields on back of high margin lending opportunities in home loan segment, while bank’s fee Income engines gain momentum over time. We apply a P/Adj.BV multiple of 1.33x to the FY21 adj. BVPS of INR 183 and arrive at a target price of INR 351 per share using SOTP approach, an upside of 14.3% over the CMP. Accordingly, we assign an “Accumulate” rating.
... Read more

ICICIdirect.com
14-May-19
Price @ Call: 306.75
Target: 400
BUY
The management is confident that balance sheet has been repaired and has guided for strong recovery (~| 17000 crore) in the coming year with modest target of 12% credit growth. We factor in fresh fund raising of | 20000 crore in H2FY20E. We upgrade the target price to | 400 from | 385, valuing at 1.5x FY21E ABV, factoring in higher profit estimates and improved (0.8%) RoE (12-13%) guidance. We reiterate BUY on dwindling asset quality woes.
... Read more

HDFC Securities
14-May-19
Price @ Call: 306.75
Target: 383
BUY
While SBIN’s profits were hit in 4QFY19 by higher provisions, best-in-class coverage was a positive outcome. A possible fund-raise will be book accretive. Maintain BUY with an SOTP of Rs 383 (1.3x Mar-21E ABV of Rs 222 + Rs 95 sub value).
... Read more

Reliance Securities
14-May-19
Price @ Call: 306.75
Target: 390
BUY
SBI’s strong liability franchise and better capital position differentiate it from other PSU peers. Moreover, industry best cost of funds also helps lower asset side risks. Upwardly revising our earnings estimates by 15%/18% for FY20E/21E owing to moderation in credit costs and lower slippages, we maintain our BUY recommendation on the stock with a revised Target Price of Rs390 (from Rs370 earlier), based on 1.4x FY21E adjusted PBV and the value of its subsidiaries, implying a FY21 P/ABV of 1.6x.
... Read more

Kotak Securities
13-May-19
Price @ Call: 308.05
Target: 410
BUY

Motilal Oswal
13-May-19
Price @ Call: 308.05
Target: 380
BUY
The credit cycle is showing signs of a recovery, as evident in the declining size of SMA-1 & 2 accounts, which stood at INR77.6b (0.4% of advances). Steady trends in the core portfolio, along with healthy recoveries/write-backs via NCLT, will likely drive a further improvement in asset quality over FY20/21. Pick-up in loan growth and resilient margins (guidance of 3.25%) are likely to keep revenue growth buoyant. This, coupled with stable opex (as one-off provisions are largely done away with), is likely to drive healthy earnings growth. Almost every lever of earnings is turning in favor of a big rebound after a dismal four-year earnings holiday. The key concern to watch would be overall macroeconomic slowdown in recent times and any new stress sectors that may impact the credit cost recovery. Our net earnings see a big upgrade (a) 31.8% for FY20 to factor in NCLT-related provisioning write- back and (b) by a modest 2.3% for FY21. We currently value the stock at 1.2x P/ABV and arrive at a target price of INR380. The stock is primed for a further re-rating as the credit cost curve keeps shifting down. Maintain Buy.
... Read more

Sharekhan
13-May-19
Price @ Call: 308.05
Target: 390
BUY
SBI trades at 1.2x its FY2021E book value, which we believe is reasonable considering it to have better operating metrics in PSU space. We thus maintain our Buy rating on the stock with revised PT of 390.
... Read more

Nirmal Bang
13-May-19
Price @ Call: 308.05
Target: 373
BUY
We have revised our NII estimates by 3.4%/3.3%, PPOP estimates by -5.1%/-5.3% and PAT estimates by 0.3%/0.4% for FY20/FY21, respectively. We have valued the standalone entity at 0.9x FY21E P/ABV, ascribing a value of Rs75 for subsidiaries and revising our target price on it to Rs373 (from Rs366 earlier).
... Read more

Prabhudas Lilladher
10-May-19
Price @ Call: 302.69
Target: 427
BUY
SBI’s core performance was better off than expectations on back of higher other income led by continued strong recovery from W.off a/c, decent NII and relatively good opex control. Earnings were dented on back of sharp provision rise based on ageing of certain legacy NPAs in the NCLT List -1 taking PCR to ~100%. Also, asset quality improved on back of lower slippages (Rs79.6bn or 1.6% of loans) v/s expectations and also incorporating few of the recent stress names. Going ahead, higher recoveries & lower slippages should improve asset quality, while better PCR of +60% (70% on corporate book and 93% on NCLT) should translate to normalization in credit cost, helping improve return ratios. We retain BUY with revised TP of Rs427 (from 361) based on 1.5x Mar-21 (rolled over from Sep-20) and Rs88 for subs.
... Read more

Rudra Shares & Stocks Brokers
15-Mar-19
Price @ Call: 291.15
Target: 319
BUY
Banks, especially PSU's in the past months gone by has faced multi- fold problems. Financial as well as liquidity crunches & above all stringent norms for banks marked panic over head of many. Despite the stated reasons, we recommend to BUY SBI which delivered se- quential growth and improved fundamentals beating our calculations and is available at attractive valuation. Estimating P/BV at 1.20x (Est. 5yr avg.) for FY20, the estimated share price turns around to Rs 319.
... Read more

ICICIdirect.com
11-Mar-19
Price @ Call: 286.8
Target: 340
BUY

Dolat Capital
8-Feb-19
Price @ Call: 284.82
Target: 320
ACCUMULATE

Edelweiss
5-Feb-19
Price @ Call: 285.11
Target: 353
BUY

Axis Direct
4-Feb-19
Price @ Call: 281.98
Target: 380
BUY

ICICIdirect.com
4-Feb-19
Price @ Call: 281.98
Target: 340
BUY

Motilal Oswal
4-Feb-19
Price @ Call: 284.3
Target: 340
BUY

Reliance Securities
4-Feb-19
Price @ Call: 284.3
Target: 340
BUY

Prabhudas Lilladher
1-Feb-19
Price @ Call: 291.97
Target: 361
BUY

Centrum
11-Jan-19
Price @ Call: 303.15
Target: 350
BUY

Indiabulls Ventures
8-Jan-19
Price @ Call: 295.7
Target: 345
BUY

SBIN Share Price Target - Broker Reports - 2018

Geojit Financial Services
26-Dec-18
Price @ Call: 291.28
Target: 345
BUY

Motilal Oswal
19-Dec-18
Price @ Call: 292.55
Target: 360
BUY

HDFC Securities
6-Nov-18
Price @ Call: 289.73
Target: 352
BUY

Motilal Oswal
6-Nov-18
Price @ Call: 289.73
Target: 370
BUY

ICICIdirect.com
6-Nov-18
Price @ Call: 289.73
Target: 340
BUY

Prabhudas Lilladher
6-Nov-18
Price @ Call: 292.13
Target: 355
BUY

Edelweiss
28-Sep-18
Price @ Call: 267.3
Target: 338
BUY

Motilal Oswal
13-Aug-18
Price @ Call: 304.45
Target: 360
BUY

HDFC Securities
13-Aug-18
Price @ Call: 304.45
Target: 340
BUY

ICICIdirect.com
13-Aug-18
Price @ Call: 296.73
Target: 340
BUY

Prabhudas Lilladher
10-Aug-18
Price @ Call: 313.02
Target: 349
BUY

Sharekhan
10-Aug-18
Price @ Call: 313.02
Target: 340
BUY

Indiabulls Ventures
27-Jun-18
Price @ Call: 263.73
Target: 302
BUY

Prabhudas Lilladher
23-May-18
Price @ Call: 250.3
Target: 349
BUY

Sharekhan
23-May-18
Price @ Call: 250.3
Target: 325
BUY

Motilal Oswal
23-May-18
Price @ Call: 250.3
Target: 365
BUY

Edelweiss
23-May-18
Price @ Call: 265.07
Target: 350
BUY

Prabhudas Lilladher
20-Mar-18
Price @ Call: 248.1
Target: 341
BUY

Edelweiss
20-Mar-18
Price @ Call: 248.1
Target: 414
BUY

Axis Direct
16-Feb-18
Price @ Call: 273.58
Target: 350
BUY

Edelweiss
12-Feb-18
Price @ Call: 296.4
Target: 420
BUY

Prabhudas Lilladher
9-Feb-18
Price @ Call: 297.76
Target: 350
BUY

Motilal Oswal
9-Feb-18
Price @ Call: 297.76
Target: 375
BUY

SBIN Share Price Target - Broker Reports - 2017

Prabhudas Lilladher
14-Dec-17
Price @ Call: 313.25
Target: 386
BUY

ICICIdirect.com
28-Nov-17
Price @ Call: 335.25
Target: 390
BUY

HDFC Securities
23-Nov-17
Price @ Call: 335.2
Target: 373
BUY

Axis Direct
16-Nov-17
Price @ Call: 329.88
Target: 380
BUY

Reliance Securities
14-Nov-17
Price @ Call: 330.25
Target: 370
BUY

Nirmal Bang
13-Nov-17
Price @ Call: 337.83
Target: 386
BUY

Motilal Oswal
11-Nov-17
Price @ Call: 326.1
Target: 415
BUY

Powermywealth.com
23-Aug-17
Price @ Call: 274.1
Target: 360
HOLD

ICICIdirect.com
14-Aug-17
Price @ Call: 280.65
Target: 340
BUY

Edelweiss
14-Aug-17
Price @ Call: 280.65
Target: 341
BUY

Reliance Securities
18-Jul-17
Price @ Call: 292.25
Target: 355
BUY

ICICIdirect.com
18-Jul-17
Price @ Call: 295
Target: 340
BUY

Motilal Oswal
22-May-17
Price @ Call: 308.15
Target: 375
BUY

ICICIdirect.com
22-May-17
Price @ Call: 298
Target: 335
BUY

HDFC Securities
22-May-17
Price @ Call: 308
Target: 348
BUY

ICICIdirect.com
17-Apr-17
Price @ Call: 289
Target: 335
BUY

Axis Direct
20-Mar-17
Price @ Call: 277
Target: 320
BUY

ICICIdirect.com
22-Feb-17
Price @ Call: 272
Target: 314
BUY

Axis Direct
17-Feb-17
Price @ Call: 276
Target: 320
BUY

Geojit Financial Services
16-Feb-17
Price @ Call: 270
Target: 315
BUY

ICICIdirect.com
13-Feb-17
Price @ Call: 272
Target: 310
BUY

KRChoksey
13-Feb-17
Price @ Call: 273
Target: 334
ACCUMULATE

HDFC Securities
13-Feb-17
Price @ Call: 276
Target: 310
BUY

Motilal Oswal
10-Feb-17
Price @ Call: 276
Target: 350
BUY

ICICIdirect.com
3-Jan-17
Price @ Call: 245.4
Target: 310
BUY

SBIN Share Price Target - Broker Reports - 2016

Systematix Shares & Stocks
8-Dec-16
Price @ Call: 259.4
Target: 285
BUY

Geojit Financial Services
17-Nov-16
Price @ Call: 278
Target: 310
BUY

Khambatta Securities
16-Nov-16
Price @ Call: 274
Target: 315
BUY

ICICIdirect.com
16-Nov-16
Price @ Call: 278
Target: 310
BUY

Centrum
15-Nov-16
Price @ Call: 273
Target: 310
BUY

KRChoksey
15-Nov-16
Price @ Call: 273
Target: 334
BUY

Religare
15-Nov-16
Price @ Call: 278.45
Target: 235
SELL

Axis Direct
15-Nov-16
Price @ Call: 273
Target: 320
BUY

Prabhudas Lilladher
14-Nov-16
Price @ Call: 273
Target: 315
BUY

Geojit Financial Services
23-Sep-16
Price @ Call: 257.35
Target: 284
BUY

Geojit Financial Services
22-Aug-16
Price @ Call: 259
Target: 284
BUY

Motilal Oswal
19-Aug-16
Price @ Call: 257.45
Target: 290
BUY

Axis Direct
16-Aug-16
Price @ Call: 243
Target: 285
BUY

Prakashgaba.com
12-Jul-16
Price @ Call: 226.45
Target: 240
HOLD

Motilal Oswal
7-Jun-16
Price @ Call: 206.35
Target: 245
BUY

Khambatta Securities
1-Jun-16
Price @ Call: 198
Target: 267
BUY

Edelweiss
27-May-16
Price @ Call: 196
Target: 261
BUY

  • SBIN - Share Price Target Potential

    keyboard_arrow_down
    BrokerageTargetPotential
    Geojit Financial Services39815.53%
    ICICIdirect.com40015.95%
    Prabhudas Lilladher41318.60%
    Nirmal Bang3657.89%
    HDFC Securities38913.57%